Navigation Links
Cost of Diabetes Care in U.S. Keeps Climbing

WEDNESDAY, March 6 (HealthDay News) -- The total cost of diabetes in the United States jumped from $174 billion in 2007 to $245 billion in 2012, a new report shows.

Last year's total cost included $176 billion in direct medical costs -- such as hospital and emergency care, medications and office visits -- and $69 billion in indirect costs, including work absenteeism, reduced productivity, unemployment caused by diabetes-related disability and lost productivity due to early death. The 2012 cost represents a 41 percent increase from 2007.

"As the number of people with diabetes grows, so does the economic burden it places upon [the United States]," Dr. Robert Ratner, chief scientific and medical officer at the American Diabetes Association, said in a news release from the association, which commissioned the study.

"When it comes to the rising cost of diabetes, one of the key factors explaining the increase is that there are many more people that are now being treated for diabetes in the U.S.," Ratner explained.

"It is important to note that while treating diabetes is expensive, it is the fact that the prevalence of the disease is increasing dramatically," Ratner added. "Recent estimates project that as many as one in three American adults will have diabetes in 2050. These numbers are alarming, and further highlight the need for our nation to address this epidemic."

Nearly 26 million adults and children in the United States have diabetes and another 79 million have prediabetes, which places them at increased risk for developing the disease.

"The cost of diabetes is rising at a rate higher than overall medical costs, with more than one in 10 health care dollars in the country being spent directly on diabetes and its complications, and more than one in five health care dollars in the U.S. going to the care of people with diagnosed diabetes," Ratner noted.

The study also found that medical costs for people with diabetes are 2.3 times higher than for those without diabetes, and that the primary cause of increased costs is the increasing number of people with diabetes.

Despite the introduction of new medications for the disease, diabetes drugs and supplies accounted for only 12 percent of the medical costs in both 2007 and 2012.

Among the other key findings:

  • Most (62 percent) of the cost for diabetes care in the United States is provided by government insurance (including Medicare, Medicaid and the military). The rest is paid for by private insurance (34 percent) or by the uninsured (3 percent).
  • Total per-person health costs are higher among women than men ($8,331 versus $7,458), and lower among Hispanics ($5,930) than among whites ($8,101) and blacks ($9,540).
  • The per-person cost of medical care attributed to diabetes was $6,649 in 2007 and $7,900 in 2012, a 19 percent increase. Overall, medical care costs in the United States rose by a comparable amount during the same time period, which indicates that the increasing cost of diabetes care is being driven by the increasing number of people with diabetes.
  • Among states, California has the largest population with diabetes and thus the highest costs, at $27.6 billion. Florida's total population is fourth among states behind California, Texas and New York, but it is second in diabetes-related costs at $18.9 billion.

The findings were released at a news conference March 6 and will appear in the April issue of the journal Diabetes Care.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases offers a diabetes prevention series.

-- Robert Preidt

SOURCE: American Diabetes Association, news release, March 6, 2013

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. How a cancer drug leads to diabetes
2. Heart failure patients with diabetes may benefit from higher glucose levels
3. Disrupted Sleep May Raise Risk for Obesity, Diabetes: Study
4. Mouse Study Hints at New Path for Diabetes Treatment
5. Common Plastics Chemical Might Boost Diabetes Risk
6. Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
7. Naturopathic care can improve blood sugar, mood in diabetes
8. Cellular pathway linked to diabetes, heart disease
9. Diabetes Groups Issue New Guidelines on Blood Sugar
10. Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned
11. Xenotransplantation as a therapy for type 1 diabetes
Post Your Comments:
Related Image:
Cost of Diabetes Care in U.S. Keeps Climbing
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: